Cryo-Cell International Inc. CCEL
4.24
0.21
5.21%
as of 25 Sep
- Market cap
- $32.5M
- P/E
- 0.0×
Follow CCEL
| May '26 | Feb '26 | Nov '25 | Aug '25 | Older periods | |
|---|---|---|---|---|---|
| 14.80% | 16.12% | 15.27% | 3.88% |
+8 more TTM periods Free account |
|
| (3.94%) | (4.26%) | (3.84%) | (0.75%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(15.37%) | (18.79%) | (18.69%) | (3.28%) | |
Average Days of Receivables |
81.03 | 79.53 | 79.16 | 78.56 | |
Free Cash Flow per Share |
0.76 | 0.63 | 0.66 | 0.78 | |
Free Cash Flow |
6.11 | 5.06 | 5.36 | 6.30 | |
Capital Expenditures |
(0.21) | (0.12) | (0.12) | (0.06) | |
Piotroski F-Score |
5.00 | 5.00 | 5.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
(96.96%) | (89.67%) | (113.20%) | (3,127.36%) | |
Accounts Receivable Turnover |
4.50 | 4.46 | 4.46 | 4.63 | |
Accounts Payable Turnover |
2.70 | 2.33 | 3.10 | 3.20 | |
Inventory Turnover |
13.92 | 12.96 | 13.83 | 10.63 | |
Average Days of Payables |
151.29 | 170.97 | 142.05 | 129.30 | |
Days of Inventory on Hand |
16.48 | 18.49 | 20.23 | 32.44 | |
Tax Rate |
(0.03) | (0.05) | 0.04 | (1.33) | |
Research and Development Expense of Revenue |
1.00% | 1.10% | 1.19% | 1.88% | |
Selling, General and Administrative Expense of Revenue |
60.89% | 59.44% | 57.72% | 58.86% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(2.56) | (1.94) | (2.26) | (13.42) | |
Depreciation/Fixed assets |
0.07 | 0.07 | 0.07 | 0.07 | |
Capex/Depreciation |
(0.15) | (0.09) | (0.08) | (0.04) | |
Revenue per Share |
3.86 | 3.88 | 3.91 | 3.94 | |
Operating CF per Share |
0.78 | 0.64 | 0.68 | 0.79 | |
Capex per Share |
(0.03) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(7.92%) | (8.52%) | (7.70%) | (1.49%) |
Columns are period end dates